- Home
- GERN vs HLF Comparison
GERN vs HLF Comparison
Compare GERN & HLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- HLF
- Stock Information
- Founded
- GERN 1990
- HLF 1980
- Country
- GERN United States
- HLF United States
- Employees
- GERN N/A
- HLF N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- HLF Other Pharmaceuticals
- Sector
- GERN Health Care
- HLF Health Care
- Exchange
- GERN Nasdaq
- HLF Nasdaq
- Market Cap
- GERN 840.7M
- HLF 745.5M
- IPO Year
- GERN 1996
- HLF N/A
- Fundamental
- Price
- GERN $1.18
- HLF $6.73
- Analyst Decision
- GERN Buy
- HLF Strong Buy
- Analyst Count
- GERN 9
- HLF 4
- Target Price
- GERN $5.13
- HLF $11.50
- AVG Volume (30 Days)
- GERN 11.5M
- HLF 2.4M
- Earning Date
- GERN 05-07-2025
- HLF 04-30-2025
- Dividend Yield
- GERN N/A
- HLF N/A
- EPS Growth
- GERN N/A
- HLF 100.43
- EPS
- GERN N/A
- HLF 2.74
- Revenue
- GERN $116,293,000.00
- HLF $4,950,500,000.00
- Revenue This Year
- GERN $194.54
- HLF N/A
- Revenue Next Year
- GERN $56.51
- HLF $3.95
- P/E Ratio
- GERN N/A
- HLF $2.45
- Revenue Growth
- GERN 22264.04
- HLF N/A
- 52 Week Low
- GERN $1.17
- HLF $5.04
- 52 Week High
- GERN $5.34
- HLF $12.79
- Technical
- Relative Strength Index (RSI)
- GERN 32.46
- HLF 44.66
- Support Level
- GERN $1.34
- HLF $6.59
- Resistance Level
- GERN $1.44
- HLF $7.53
- Average True Range (ATR)
- GERN 0.10
- HLF 0.48
- MACD
- GERN 0.00
- HLF 0.04
- Stochastic Oscillator
- GERN 3.23
- HLF 25.46
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About HLF Herbalife Ltd.
Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management, targeted nutrition, Energy, Sports and Fitness, Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Latin America, EMEA, Asia Pacific regions, and China.